ZA200509079B - Novel 14 and 15 membered-ring compounds - Google Patents

Novel 14 and 15 membered-ring compounds

Info

Publication number
ZA200509079B
ZA200509079B ZA200509079A ZA200509079A ZA200509079B ZA 200509079 B ZA200509079 B ZA 200509079B ZA 200509079 A ZA200509079 A ZA 200509079A ZA 200509079 A ZA200509079 A ZA 200509079A ZA 200509079 B ZA200509079 B ZA 200509079B
Authority
ZA
South Africa
Prior art keywords
membered
novel
ring compounds
compounds
ring
Prior art date
Application number
ZA200509079A
Other languages
English (en)
Inventor
Alihodzic Sulejman
Jarvest Richard Lewis
Pavlovic Drazen
Forrest Andrew Keith
Lazarevski Gorjana
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Inst D O O filed Critical Glaxo Group Ltd
Publication of ZA200509079B publication Critical patent/ZA200509079B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200509079A 2003-05-13 2005-11-09 Novel 14 and 15 membered-ring compounds ZA200509079B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0310986.5A GB0310986D0 (en) 2003-05-13 2003-05-13 Novel compounds

Publications (1)

Publication Number Publication Date
ZA200509079B true ZA200509079B (en) 2007-02-28

Family

ID=9957984

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200509079A ZA200509079B (en) 2003-05-13 2005-11-09 Novel 14 and 15 membered-ring compounds

Country Status (22)

Country Link
US (1) US7569550B2 (enExample)
EP (1) EP1628988B1 (enExample)
JP (1) JP2007502313A (enExample)
KR (1) KR20060026407A (enExample)
CN (1) CN1849328A (enExample)
AR (1) AR044309A1 (enExample)
AT (1) ATE341560T1 (enExample)
AU (1) AU2004238528A1 (enExample)
BR (1) BRPI0410246A (enExample)
CA (1) CA2525452A1 (enExample)
CL (1) CL2004001010A1 (enExample)
DE (1) DE602004002696T2 (enExample)
DK (1) DK1628988T3 (enExample)
ES (1) ES2273255T3 (enExample)
GB (1) GB0310986D0 (enExample)
HR (1) HRP20060448T3 (enExample)
MX (1) MXPA05012163A (enExample)
PL (1) PL1628988T3 (enExample)
PT (1) PT1628988E (enExample)
RU (1) RU2005134908A (enExample)
WO (1) WO2004101586A1 (enExample)
ZA (1) ZA200509079B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
WO2007054295A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited New 4*-substituted erythromycin derivative
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
DE602006015919D1 (de) * 2005-01-13 2010-09-16 Glaxosmithkline Zagreb Makrolide mit entzündungshemmender wirkung
JP2008540503A (ja) 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用なエーテル結合マクロライド
WO2007054296A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited Macrolones
JP5437394B2 (ja) 2009-01-30 2014-03-12 グラクソ グループ リミテッド 抗炎症性マクロライド
CN111574575B (zh) * 2020-04-29 2022-05-17 北京理工大学 一种含有大环内酯基的喹喏酮衍生物、制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL93936A (en) * 1989-03-28 1994-06-24 Abbott Lab History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
DE69723848T2 (de) * 1996-05-07 2004-07-01 Abbott Laboratories, Abbott Park 3-descladinose-2,3-anhydroerythromycin-derivate
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
JP4311203B2 (ja) * 2001-08-08 2009-08-12 大正製薬株式会社 １１ａ−アザライド化合物及びその製造方法
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
PL1628988T3 (pl) 2007-03-30
GB0310986D0 (en) 2003-06-18
WO2004101586A1 (en) 2004-11-25
CA2525452A1 (en) 2004-11-25
US7569550B2 (en) 2009-08-04
RU2005134908A (ru) 2006-06-27
DK1628988T3 (da) 2007-02-05
AR044309A1 (es) 2005-09-07
JP2007502313A (ja) 2007-02-08
MXPA05012163A (es) 2006-05-19
AU2004238528A1 (en) 2004-11-25
CL2004001010A1 (es) 2005-03-18
DE602004002696D1 (de) 2006-11-16
KR20060026407A (ko) 2006-03-23
EP1628988A1 (en) 2006-03-01
ATE341560T1 (de) 2006-10-15
CN1849328A (zh) 2006-10-18
US20070185117A1 (en) 2007-08-09
BRPI0410246A (pt) 2006-05-16
EP1628988B1 (en) 2006-10-04
PT1628988E (pt) 2007-01-31
HRP20060448T3 (hr) 2007-03-31
ES2273255T3 (es) 2007-05-01
DE602004002696T2 (de) 2007-08-16

Similar Documents

Publication Publication Date Title
GB0309138D0 (en) Design 2
TW595857U (en) 091219345
GB0229742D0 (en) Novel compounds and uses thereof
SI1531673T1 (sl) Novi 2-piridiletilbenzamidni derivati
EP1617807A4 (en) SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
SI1628989T1 (sl) Nove cikliäśne spojine s 14 in 15 obroäśnimi äśleni
DE502004012210D1 (en) Ment yellow 74
GB0220501D0 (en) Push 22
PL1628988T3 (pl) Nowe 14- i 15-członowe pierścieniowe związki
SI1628988T1 (sl) Nove 14- in 15-clenske obrocne spojine
GB0313308D0 (en) Design 1
GB0206835D0 (en) Iv 2
GB2406658B (en) Novel 360 camera
GB0321251D0 (en) Doormate 2000
GB0222015D0 (en) Means of assembly-bozz 2
GB2425310B (en) N-aryloxypropanolyl-N' -phenethyl-urea
GB0209835D0 (en) Easy 1
GB0205625D0 (en) Lazline 3000
GB0203312D0 (en) 8323610001
GB0323939D0 (en) Art 7
GB0322097D0 (en) Carry 3
GB0318769D0 (en) Improved 'smpsogi'
GB0327449D0 (en) 100 1st
GB0314147D0 (en) Design 1
GB0219989D0 (en) Carry 3